SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950135-04-001494
Filing Date
2004-03-24
Accepted
2004-03-24 14:34:58
Documents
5
Period of Report
2004-03-23
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 ARIAD PHARMACEUTICALS, INC b49975ape8vk.htm 8-K 15694
3 EX-1.1 UNDERWRITING AGREEMENT DATED MARCH 23, 2004 b49975apexv1w1.txt EX-1.1 98481
4 EX-5.1 OPINION OF MINTZ, LEVIN, COHN, FERRIS b49975apexv5w1.txt EX-5.1 5212
5 EX-99.1 PRESS RELEASE DATED MARCH 24, 2004 b49975apexv99w1.htm EX-99.1 5903
6 GRAPHIC b49975apariadlogo.gif GRAPHIC 933
  Complete submission text file 0000950135-04-001494.txt   128373
Mailing Address 26 LANDSDOWNE CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400
ARIAD PHARMACEUTICALS INC (Filer) CIK: 0000884731 (see all company filings)

IRS No.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-76486 | Film No.: 04687039
SIC: 2836 Biological Products, (No Diagnostic Substances)